HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Yunlong Cao Selected Research

Yunlong Cao Research Topics

Disease

8Infections
01/2024 - 01/2021
4COVID-19
12/2023 - 11/2020
3Breakthrough Infections
01/2024 - 11/2022
1Communicable Diseases (Infectious Diseases)
01/2020

Drug/Important Bio-Agent (IBA)

6Neutralizing AntibodiesIBA
01/2023 - 01/2020
3Monoclonal AntibodiesIBA
12/2023 - 01/2023
3EpitopesIBA
11/2023 - 11/2020
3N-methyl-valyl-amiclenomycin (BA 2)IBA
01/2023 - 01/2022
3VaccinesIBA
01/2023 - 01/2022
3N-(2-cyanoethylene)urea (BA 1)IBA
11/2022 - 01/2022
2Nasal SpraysIBA
12/2023 - 03/2023
2AntibodiesIBA
11/2023 - 01/2022
1mRNA VaccinesIBA
01/2024
1Angiotensin-Converting Enzyme 2IBA
01/2024
1Immunoglobulin A (IgA)IBA
01/2024
1Secretory Immunoglobulin A (SIgA)IBA
01/2024
1Immunoglobulin G (IgG)IBA
01/2024
1DXP-604IBA
01/2024
1Proteins (Proteins, Gene)FDA Link
01/2022
1SARS-CoV-2 spike proteinIBA
01/2022
1sinovac COVID-19 vaccineIBA
01/2021
1ZF2001 COVID-19 vaccineIBA
01/2021
1Inactivated VaccinesIBA
01/2021
1Subunit VaccinesIBA
01/2021

Therapy/Procedure

1Intranasal Administration
01/2024